The clinical impact of single nucleotide polymorphism on diffuse large B cell lymphoma

ZHANG Yan,HONG Xiao-nan
DOI: https://doi.org/10.3781/j.issn.1000-7431.2011.03.016
2011-01-01
Tumor
Abstract:Diffuse large B cell lymphoma(DLBCL) is the most common subtype of non-Hodgkin lymphoma,and also a typical polygenic disease.Single nucleotide polymorphism(SNP) is the third generation of molecular genetic markers of human population.It defines as the polymorphism of a variant nucleotide in a particular location of human genome.This review introduces the clinical impact of SNP on DLBCL.
What problem does this paper attempt to address?